2024 业绩低于我们预期公司公布2024 年业绩:收入57.73 亿港元,同比减少10.7%(若以人民币计减少9.6%);归母净利润10.61 亿港元,同比减少19.5%,低于我们预期,主要由于安瓿小水针受集采影响下滑幅度超预期。发展趋势2024 年,大输液龙头销量保持增长。2024 年,公司静脉输液销售量同比+6.7%;收入约37.35 亿港元,同比下滑7.6%。其中直立式软袋输液收益...
Source Link2024 业绩低于我们预期公司公布2024 年业绩:收入57.73 亿港元,同比减少10.7%(若以人民币计减少9.6%);归母净利润10.61 亿港元,同比减少19.5%,低于我们预期,主要由于安瓿小水针受集采影响下滑幅度超预期。发展趋势2024 年,大输液龙头销量保持增长。2024 年,公司静脉输液销售量同比+6.7%;收入约37.35 亿港元,同比下滑7.6%。其中直立式软袋输液收益...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.